COVID-19 era shifted fungal infection patterns in transplant patients, study finds
NCT ID NCT06900114
First seen Mar 20, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study looked back at medical records of 60 adults with blood cancers who had a stem cell transplant and later developed a rare fungal infection called mucormycosis. Researchers compared cases before and during the COVID-19 pandemic to see how the virus, new diagnostic tools, and treatments affected the infection's frequency, diagnosis, and outcomes. The goal is to improve future care for these high-risk patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Conditions
Explore the condition pages connected to this study.